Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Kelvin Allenson

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5077741142. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
56
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 9

  1. Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. Co-author DOI 10.1016/j.jss.2026.02.012↗
  2. Prehabilitation as a Strategy to Modulate the Tumor Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms27198900↗
  3. Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. Co-author DOI 10.3390/healthcare13020114↗
  4. The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization. First author DOI 10.1016/j.sopen.2023.02.001↗
  5. Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being. Co-author DOI 10.1007/s10865-022-00354-x↗
  6. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2018.09.022↗
  7. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Co-author DOI 10.1093/annonc/mdx542↗
  8. Dynamic changes during the treatment of pancreatic cancer. Co-author DOI 10.18632/oncotarget.24483↗
  9. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Co-author DOI 10.1093/annonc/mdx004↗

Closest collaborators

The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pamela Joy Hodul · 3 shared papers, 2022–2025 · strength 0.55
  2. Jennifer B. Permuth · 3 shared papers, 2022–2025 · strength 0.55
  3. Brent Taiting Xia · 2 shared papers, 2022–2025 · strength 0.39
  4. Dae Won Kim · 2 shared papers, 2022–2025 · strength 0.39
  5. Sanjna Sandeep · 1 shared paper, 2026 · strength 0.33
  6. Atiya F. Dhala · 1 shared paper, 2026 · strength 0.33
  7. Jason W. Denbo · 2 shared papers, 2022–2023 · strength 0.29
  8. Mokenge Peter Malafa · 2 shared papers, 2022–2023 · strength 0.29
  9. Jason B. Fleming · 2 shared papers, 2022–2023 · strength 0.29
  10. Nicole Nardella · 1 shared paper, 2025 · strength 0.26
  11. Matthew H. G. Katz · 4 shared papers, 2017–2019 · strength 0.24
  12. Vincent Bernard · 4 shared papers, 2017–2019 · strength 0.24
  13. Anirban Maitra · 4 shared papers, 2017–2019 · strength 0.24
  14. Gauri Rajani Varadhachary · 4 shared papers, 2017–2019 · strength 0.24
  15. Hector A. Alvarez · 4 shared papers, 2017–2019 · strength 0.24
  16. Nestor F. Esnaola · 1 shared paper, 2026 · strength 0.23
  17. Ashish Saharia · 1 shared paper, 2026 · strength 0.23
  18. Ahmed Elaileh · 1 shared paper, 2026 · strength 0.23
  19. Ahmed Osama Gaber · 1 shared paper, 2026 · strength 0.23
  20. Maen Abdelrahim · 1 shared paper, 2026 · strength 0.23
  21. Ashton Anthony Connor · 1 shared paper, 2026 · strength 0.23
  22. Kirk Heyne · 1 shared paper, 2026 · strength 0.23
  23. Youssef E. Dib · 1 shared paper, 2026 · strength 0.23
  24. Robert A. Wolff · 3 shared papers, 2018–2019 · strength 0.19
  25. Ignacio Ivan Wistuba · 3 shared papers, 2017–2018 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.